H.R. 2319

119th Congress

Reported

Women and Lung Cancer Research and Preventive Services Act of 2025

Sponsored byDemocrat:Rep. Boyle, Brendan F. [D-PA-2]PA· Introduced 25 mars 2025
Open on Congress.gov

2

Cosponsors

15

Actions

0

Amendments

1

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

22 avril 2026·3 months ago

Summary

Reported to House · Updated 2 avril 2026

Women and Lung Cancer Research and Preventive Services Act of 2025

This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.

The review must

  • report on the status of existing research and current knowledge gaps;
  • identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
  • provide recommendations for a national lung cancer screening strategy and public education campaign.

Timeline

15 actions

  1. Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

    22 avril 2026 · Calendars

  2. Mrs. Harshbarger moved to suspend the rules and pass the bill.

    21 avril 2026 · Floor

  3. Considered under suspension of the rules. (consideration: CR H3020-3021)

    21 avril 2026 · Floor

  4. DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.

    21 avril 2026 · Floor

  5. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)

    21 avril 2026 · Floor

  6. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)

    21 avril 2026 · Floor

  7. Motion to reconsider laid on the table Agreed to without objection.

    21 avril 2026 · Floor

  8. Placed on the Union Calendar, Calendar No. 332.

    18 novembre 2025 · Calendars

  9. Reported by the Committee on Energy and Commerce. H. Rept. 119-382.

    18 novembre 2025 · Committee

  10. Reported by the Committee on Energy and Commerce. H. Rept. 119-382.

    18 novembre 2025 · Committee

  11. Committee Consideration and Mark-up Session Held

    29 avril 2025 · Committee

  12. Ordered to be Reported by Voice Vote.

    29 avril 2025 · Committee

  13. Referred to the House Committee on Energy and Commerce.

    25 mars 2025 · IntroReferral

  14. Introduced in House

    25 mars 2025 · IntroReferral

  15. Introduced in House

    25 mars 2025 · IntroReferral

Sponsorship

2 cosponsors

Sponsor

Democrat:Rep. Boyle, Brendan F. [D-PA-2]PA

Cosponsors

  • Republican2100%

Classification

Policy area

Health

Legislative subjects

CancerCardiovascular and respiratory healthGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsWomen's health

Committees

1

  • Energy and Commerce Committee

    House · Standing

    • Referred To25 Mar 2025
    • Markup By29 Apr 2025
    • Reported By19 Nov 2025

Reports

Cosponsor momentum

Cumulative over time

Cosponsors grew from 0 on 25 mars 2025 to 2 on 15 septembre 2025.

Pelosi Tracker
Follow on XRejoignez notre Discord
PolitiquesProjets de loiPortefeuillesTarifsÀ proposMentions légalesConditions d'utilisationPolitique de confidentialité
English
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.